跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,625 条关于
“Innocare Pharma”
全部
9,625
临床试验
4,097
药物
1,117
机构
1,221
资讯
3,190
去年
InnoCare Pharma's ICP-488 Demonstrates Positive Phase II Results for Psoriasis
去年
InnoCare Pharma's TYK2 Inhibitor ICP-488 Shows Promising Phase II Results for Psoriasis Treatment
去年
InnoCare's Orelabrutinib Shows Promise in Treating Primary Immune Thrombocytopenia
去年
InnoCare's Orelabrutinib Shows Over 90% Reduction in MS Brain Lesions in Phase II Trial
4个月前
Zenas BioPharma Initiates Phase 1 Trial of ZB021, First Oral IL-17 Inhibitor for Autoimmune Diseases
2年前
Mantle Cell Lymphoma Pipeline Shows Promise with Novel Targeted Therapies
去年
InnoCare and KeyMed Strike $520M Licensing Deal with Prolium for Novel CD20xCD3 Bispecific Antibody
10天前
China NMPA Clears InnoCare's Bispecific ADC ICP-B381 for Clinical Trials
上个月
Innocare's Oral Psoriasis Drug Fadeucravacitinib Meets Primary Goal in Phase III Trial, Regulatory Filing Planned
去年
InnoCare Doses First Subject in Phase III Trial of TYK2 Inhibitor ICP-332 for Atopic Dermatitis
第 1 页,共 319 页
上一页
下一页